5 Key Takeaways

• 1

  Myopia is increasing globally, prompting a focus on innovative management strategies, including specialty lenses and combination therapies.

• 2

  Ortho-k and soft multifocal lenses are effective in slowing myopia progression, with new designs accommodating a wider range of patients.

• 3

  Combination therapy using atropine with specialty lenses may enhance myopia control, although further research is needed on its effects.

• 4

  Emerging technologies, such as smart contact lenses and light-based therapies, show promise for future myopia management but face engineering challenges.

• 5

  Advancements in AI and big data analytics may lead to more personalized myopia treatment plans based on individual biometric data.